Literature DB >> 18299493

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women.

Kristine E Ensrud1, Susan K Ewing, Brent C Taylor, Howard A Fink, Peggy M Cawthon, Katie L Stone, Teresa A Hillier, Jane A Cauley, Marc C Hochberg, Nicolas Rodondi, J Kathleen Tracy, Steven R Cummings.   

Abstract

BACKGROUND: Frailty, as defined by the index derived from the Cardiovascular Health Study (CHS index), predicts risk of adverse outcomes in older adults. Use of this index, however, is impractical in clinical practice.
METHODS: We conducted a prospective cohort study in 6701 women 69 years or older to compare the predictive validity of a simple frailty index with the components of weight loss, inability to rise from a chair 5 times without using arms, and reduced energy level (Study of Osteoporotic Fractures [SOF index]) with that of the CHS index with the components of unintentional weight loss, poor grip strength, reduced energy level, slow walking speed, and low level of physical activity. Women were classified as robust, of intermediate status, or frail using each index. Falls were reported every 4 months for 1 year. Disability (> or =1 new impairment in performing instrumental activities of daily living) was ascertained at 4(1/2) years, and fractures and deaths were ascertained during 9 years of follow-up. Area under the curve (AUC) statistics from receiver operating characteristic curve analysis and -2 log likelihood statistics were compared for models containing the CHS index vs the SOF index.
RESULTS: Increasing evidence of frailty as defined by either the CHS index or the SOF index was similarly associated with an increased risk of adverse outcomes. Frail women had a higher age-adjusted risk of recurrent falls (odds ratio, 2.4), disability (odds ratio, 2.2-2.8), nonspine fracture (hazard ratio, 1.4-1.5), hip fracture (hazard ratio, 1.7-1.8), and death (hazard ratio, 2.4-2.7) (P < .001 for all models). The AUC comparisons revealed no differences between models with the CHS index vs the SOF index in discriminating falls (AUC = 0.61 for both models; P = .66), disability (AUC = 0.64; P = .23), nonspine fracture (AUC = 0.55; P = .80), hip fracture (AUC = 0.63; P = .64), or death (AUC = 0.72; P = .10). Results were similar when -2 log likelihood statistics were compared.
CONCLUSION: The simple SOF index predicts risk of falls, disability, fracture, and death as well as the more complex CHS index and may provide a useful definition of frailty to identify older women at risk of adverse health outcomes in clinical practice.

Entities:  

Mesh:

Year:  2008        PMID: 18299493     DOI: 10.1001/archinternmed.2007.113

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  292 in total

1.  Frailty criteria and cognitive performance are related: data from the FIBRA study in Ermelino Matarazzo, São Paulo, Brazil.

Authors:  M S Yassuda; A Lopes; M Cachioni; D V S Falcao; S S T Batistoni; V V Guimaraes; A L Neri
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

2.  Stress Regulation as a Link between Executive Function and Pre-Frailty in Older Adults.

Authors:  R A Roiland; F Lin; C Phelan; B P Chapman
Journal:  J Nutr Health Aging       Date:  2015-10       Impact factor: 4.075

3.  Predictive performance of four frailty measures in an older Australian population.

Authors:  Imaina S Widagdo; Nicole Pratt; Mary Russell; Elizabeth E Roughead
Journal:  Age Ageing       Date:  2015-11       Impact factor: 10.668

Review 4.  Cellular Senescence and the Biology of Aging, Disease, and Frailty.

Authors:  Nathan K LeBrasseur; Tamara Tchkonia; James L Kirkland
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2015-10-20

5.  The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort.

Authors:  Joanne Allen; Fiona M Alpass; Christine V Stephens
Journal:  Qual Life Res       Date:  2018-05-03       Impact factor: 4.147

6.  The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.

Authors:  Claire Johnston; Sarah N Hilmer; Andrew J McLachlan; Slade T Matthews; Peter R Carroll; Carl M Kirkpatrick
Journal:  Eur J Clin Pharmacol       Date:  2014-02-14       Impact factor: 2.953

7.  The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors.

Authors:  Matthew R Baldwin; M Cary Reid; Amanda A Westlake; John W Rowe; Evelyn C Granieri; Hannah Wunsch; Thuy-Tien Dam; Daniel Rabinowitz; Nathan E Goldstein; Mathew S Maurer; David J Lederer
Journal:  J Crit Care       Date:  2014-01-06       Impact factor: 3.425

8.  Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.

Authors:  G Berrut; S Andrieu; I Araujo de Carvalho; J P Baeyens; H Bergman; B Cassim; F Cerreta; M Cesari; H B Cha; L K Chen; A Cherubini; M Y Chou; A J Cruz-Jentoft; L De Decker; P Du; B Forette; F Forette; A Franco; R Guimaraes; L M Guttierrez-Robledo; J Jauregui; V Khavinson; W J Lee; L N Peng; C Perret-Guillaume; M Petrovic; F Retornaz; K Rockwood; L Rodriguez-Manas; C Sieber; G Spatharakis; O Theou; E Topinkova; B Vellas; A Benetos
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

9.  Measuring frailty in heart failure: a community perspective.

Authors:  Sheila M McNallan; Alanna M Chamberlain; Yariv Gerber; Mandeep Singh; Robert L Kane; Susan A Weston; Shannon M Dunlay; Ruoxiang Jiang; Véronique L Roger
Journal:  Am Heart J       Date:  2013-09-17       Impact factor: 4.749

10.  Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.

Authors:  M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; Y Sato; J S Moon; A Harano; K Hazaki; E Kajita; M Hamada; K Arai; K Tomioka; N Okamoto; N Kurumatani
Journal:  Osteoporos Int       Date:  2016-10-18       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.